跳至主要内容
临床试验/JPRN-UMIN000005849
JPRN-UMIN000005849已完成未知

Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy - Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy

Department of Ophthalmology, Osaka Univeristy Medical School0 个研究点目标入组 40 人开始时间: 2011年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

In a 4-month placebo-controlled study with 20-mg lutein supplementation, macular pigment optical density (MPOD) did not increase in central serous chorioretinopathy (CSC). Lutein supplementation maintained the MPOD in CSC patients with low plasma lutein.

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Hard exudate or subretinal hemorrhage within subretinal fluid 2)Invisible fundus 3)Visual acuity less than 0.01 4)Difficulty to measure macular pigment 5)After vitrectomy 6)Past supplementaion with lutein

研究者

发起方
Department of Ophthalmology, Osaka Univeristy Medical School

相似试验